Global Influenza Medication Market in-Depth Analysis and Forecast Assumptions Till 2025

North America leads the global market with a major contribution of the U.S. owing to increasing adoption of advanced and high-cost drug therapies, increased treatment rate, and favorable reimbursement policies in the country.


Albany, NY -- (SBWire) -- 02/07/2018 --A fresh study, focusing on the viral infectious disease, named 'Influenza' has been broadcasted to the wide repository of Market Research Hub (MRH), which is titled as "Influenza Medication Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 – 2025". Influenza is a common contagious disease with flu-like symptoms. It has been analyzed that an estimated 200,000 people are hospitalized due to flu infection in the U.S. each year; of these 36,000 dies due to flu complications. Therefore, favorable policies for treatment and prevention of influenza by the government in developed regions have grown expressively. This consequently acts as a prime driver for influenza medication market growth during the forecast period 2017 to 2025.

Request For Sample Report:

Market Overview

Influenza, also known as flu, is a respiratory disease caused by an influenza virus. As per recent studies, the global influenza medication market chiefly gains momentum from the increased spending on various immunization programs. Besides this, research and development activities conducted by the market players aimed at launching novel therapeutics will enable the market gain strength in the coming years. The research evaluates that the global influenza medication market, which raised at US$1,699.7 mn in 2016, is ready to reach US$2,012.6 mn by the end of 2025, expanding at a moderate 1.4% CAGR during forecast 2017-2025.

Initially, the report begins with an overview of the global influenza medication market, evaluating market performance in terms of revenue, followed by analysis of key trends, drivers, and restraints witnessed in the global market. In order to understand the geographical occurrence of the influenza medication market, the report studies market's performance in North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Regionally, North America held top position and within the region the US has emerged as the most lucrative market for influenza medication. This is because of the increasing adoption of advanced and high-cost drug therapies, increased treatment rate, and favorable reimbursement policies in the country.

Furthermore, the study on influenza medication market segments the global market on the basis of product and distribution channel. The product category is further sub-segmented into oseltamivir, amantadine, zanamivir, peramivir, rimantadine, inosine and others including laninamivir octanoate. Of these, oseltamivir held lead with a share of 48.8% in the global market in 2016. In term of distribution channels, global influenza medications market is divided into clinics, pharmacies, hospitals and others.

Browse Full Report with TOC-

Competitive Landscape

At last, the competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. In this section, the report also profiles key players operating in the Influenza Medication Market which are F. Hoffmann-La Roche Ltd., Daiichi Sankyo Company, GlaxoSmithKline plc, Natco Pharma, Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis AG), and Mylan, Inc.

Enquire about this Report-

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at -

Media Relations Contact

Mark Hub
Market Research HUB

View this press release online at: